Shanghai, China

Zhubo Liu

This inventor holds 1 USPTO granted patent and 8 published patent applications, plus 1 CIPO patent. Top assignees: Genfleet Therapeutics (Shanghai) Inc., Zhejiang Genfleet Therapeutics Co., Ltd.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhubo Liu: A Contributor to the Biotechnology Landscape in China

Introduction

Zhubo Liu is a prominent figure in the biotechnology industry in China, contributing his expertise to various esteemed companies. Although he holds no patents currently, his work has significantly impacted the field of therapeutics through his roles in leading companies.

Latest Patents

As of now, Zhubo Liu does not have any patents attributed to his name. However, his contributions to research and development within his professional capacity continue to lay the groundwork for future innovations.

Career Highlights

Zhubo Liu has worked with noteworthy companies in the biotechnology sector, including Genfleet Therapeutics Inc. and Zhejiang Genfleet Therapeutics Co., Ltd. His roles in these organizations reflect his commitment to advancing therapeutic solutions and improving patient care through innovative research.

Collaborations

Throughout his career, Zhubo Liu has collaborated with talented individuals, most notably Xiaoming Xu. Working alongside such esteemed colleagues, Liu has contributed to a dynamic exchange of ideas, driving forward the initiatives within the companies he has served.

Conclusion

Zhubo Liu's journey in the biotechnology industry underscores his dedication to innovation and collaboration. While he may not currently hold any patents, his work with leading companies and his partnerships with notable professionals such as Xiaoming Xu highlight his significant contributions to the field. As the biotechnology landscape evolves, Liu's proactive engagement suggests a promising future ahead for both him and the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…